News

Dr. Goodenowe presents at Peptide World Congress 2022

Join Dr. Goodenowe as he presents as a keynote speaker at the Peptide World Congress in Las Vegas, October 21 & 22! Discover the cutting edge, proprietary scientific research and advances that can predict cognitive decline, neurodegenerative disease, and various neurological disorders.  The Most Influential Biomarkers for Aging and Disease Date: Saturday, October 22, 2022Time: …

Dr. Goodenowe presents at Peptide World Congress 2022 Read More »

Dr. Goodenowe presents at Frontiers in Neurology and Brain Health: Lecture 1

Join Dr. Goodenowe at the A4M Frontiers in Neurology and Brain Health Summit in Boston, MA, September 16 – 18, 2022! Learn how neuropsychiatric and neurodegenerative disorders are on the rise, and discover how Dr. Goodenowe’s cutting edge treatments such as lipid therapy, nutritional approaches, and regenerative therapies can reverse Alzheimer’s disease and cognitive decline …

Dr. Goodenowe presents at Frontiers in Neurology and Brain Health: Lecture 1 Read More »

Dr. Goodenowe presents at Frontiers in Neurology and Brain Health: Lecture 2

Join Dr. Goodenowe at his 2nd lecture at the A4M Frontiers in Neurology and Brain Health Summit in Boston, MA, September 16 – 18, 2022! Learn how the body is like a hybrid electric car (what?!) and which pump runs our system! Dr. Goodenowe unveils critical research studies and explains in detail how lipid therapy, …

Dr. Goodenowe presents at Frontiers in Neurology and Brain Health: Lecture 2 Read More »

Dr. Goodenowe: Brain Ethanolamine Phospholipids, Neuropathy, & Cognition Paper Published

A new paper by Dr. Goodenowe published by Frontiers in Cell Development and Biology is now available here. ‘Brain Ethanolamine Phospholipids, Neuropathology and Cognition: A Comparative Post-Mortem Analysis of Structurally Specific Plasmalogen and Phosphatidyl Species‘ dives into the analyses performed on one hundred temporal cortex brain samples and findings which highlight causes of cognitive impairment, …

Dr. Goodenowe: Brain Ethanolamine Phospholipids, Neuropathy, & Cognition Paper Published Read More »

Interview with Brian Crombie Sauga 960 AM

Thank you Brain Crombie for the opportunity to have Dr. Dayan Goodenowe on your radio interview to discuss the important research that has happened since the publication of Dr. Goodenowe’s Breaking Alzheimer’s book last year, and the decades of research that led up to the release of the book. View the full interview here.

13th Annual Rush Alzheimer’s Disease Center Meeting

Dr. Goodenowe presents at the 13th Annual Rush Alzheimer’s Disease Center ROSMAP Investigator’s Meeting 2022 at the Rush University Medical Center in Chicago, IL. Dr. Goodenowe presents on Tuesday, July 12, 2022; his presentation is titled Plasmalogens, Neuropathology, and Cognition – Update on Recent Advances and Overview of MARS Project.  The Religious Orders Study/Memory and …

13th Annual Rush Alzheimer’s Disease Center Meeting Read More »

ProdromeNeuro Alzheimer’s Clinical Trial Published

The results from our clinical trial with Dr. Sheldon Jordan are now published in a peer reviewed journal here. ProdromeNeuroTM plasmalogen supplement successfully improved cognition and mobility in a recent Alzheimer’s disease clinical trial, proving Dr. Dayan Goodenowe’s 15-year theory outlined in his new book Breaking Alzheimer’swhere he explains his scientific journey to expose the …

ProdromeNeuro Alzheimer’s Clinical Trial Published Read More »